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Background: Hereditary hearing loss is genetically heterogeneous, and hundreds of mutations in than 60 genes
are involved in this disease. Therefore, it is difficult to identify the causative gene mutations involved. In this study,
we combined targeted genomic capture and massively parallel sequencing (MPS) to address this issue.
Methods: Using targeted genomic capture and MPS, 104 genes and three microRNA regions were selected and
simultaneously sequenced in 23 unrelated probands of Chinese families with nonsyndromic hearing loss. The
results were validated by Sanger sequencing for all available members of the probands’ families. To analyze the
possible pathogenic functional effects of the variants, three types of prediction programs (Mutation Taster,
PROVEAN and SIFT) were used. A total of 195 healthy Chinese Han individuals were compared as controls to verify
the novel causative mutations.
Results: Of the 23 probands, six had mutations in DFNA genes [WFS1 (n = 2), COCH, ACTG1, TMC1, and POU4F3] known
to cause autosomal dominant nonsyndromic hearing loss. These included one novel in-frame indel mutation, three
novel missense mutations and two reported missense mutations. Furthermore, one proband from a family with
recessive DFNB carried two monoallelic mutations in the GJB2 and USH2A genes. All of these mutations co-segregated
with the hearing loss phenotype in 36 affected individuals from 7 families and were predicted to be pathogenic.
Conclusions: Mutations in uncommon deafness genes contribute to a portion of nonsyndromic deafness cases. In the
future, critical gene mutations may be accurately and quickly identified in families with hereditary hearing loss by
targeted genomic capture and MPS.
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Hearing loss is an extremely common problem worldwide,
and it is one of the most genetically heterogeneous disor-
ders occurring in humans. Approximately half of the cases
have a genetic etiology, including nonsyndromic hearing
loss (NSHL) and syndromic hearing loss (SHL). NSHL as
the sole defect accounts for seventy percent or more of
deafness cases, and different modes of inheritance have
been observed. To date, 65 genes with more than 1000
discrete deafness-causing mutations have been identified
[1]. SHL comprises the remaining 30% of hearing loss* Correspondence: caoxin@njmu.edu.cn; xing-gq@163.com
1Department of Biotechnology, School of Basic Medical Science, Nanjing
Medical University, Nanjing 210029, PR China
2Department of Otolaryngology, The First Affiliated Hospital of Nanjing
Medical University, Nanjing 210029, PR China
© 2014 Wei et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.cases, and it appears accompanied by other medical or
physical findings. Similar to NSHL, SHL is associated with
a growing list of causative genes and hearing loss syn-
dromes [2]. Thus, the discovery of a causative gene (muta-
tion) of hereditary hearing loss is necessary to resolve the
clinical and genetic heterogeneity of deafness.
Previously, most deafness genes (mutations) have been
identified through traditional positional cloning (Sanger
sequencing), which is an expensive and time-consuming
process. More recently, next-generation sequencing, which
is also known as massively parallel sequencing (MPS), has
been introduced as an alternative approach to more trad-
itional methods [3-5]. Whole-exome sequencing (WES)
allows for the targeted enrichment and resequencing of
nearly all exons of protein-coding genes and identifies. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ingly, WES uses next-generation technologies to provide a
transformational approach for identifying causative muta-
tions of Mendelian disorders. Different targeted genomic
capture methods and MPS have been successfully applied
to detect gene mutations in relatively small sets of deaf-
ness families [6-9]. In the present study, we performed tar-
geted genomic capture and MPS to screen 104 genes and
three microRNA regions that are known to be responsible
for hereditary hearing loss in 23 unrelated probands of
Chinese families with NSHL. We identified six causative
variants in DFNA genes, including four novel mutations,
and a novel combination of two monoallelic mutations in
GJB2 and USH2A. This study provides a reliable strategy
for the routine genetic diagnosis of hearing loss.Materials and methods
Subjects and pre-exclusion of frequently reported
deafness genes
A total of 143 available members of twenty-three Chinese
families were recruited from the Otology Clinic of the
First Affiliated Hospital at the Nanjing Medical University,
Nanjing, China. Each family had at least 2 hearing-
impaired individuals. All affected members in these fam-
ilies were diagnosed as having hereditary NSHL by a
complete hearing evaluation, general examination and
medical history collection. Peripheral blood samples were
obtained from available members of these families, and
genomic DNA was extracted using a blood genomic DNA
extraction kit (TianGen, Beijing, China) according to the
manufacturer’s protocol.
Each proband of the 23 families was pre-tested for
nine hotspot mutations of deafness genes that have been
reported in Chinese individuals with a Deafness Gene
Mutation Detection Array Kit (Capital Bio Corporation,
Beijing, China), as previously described [10]. The muta-
tions included c.35delG, c.176del16bp, c.235delC and
c.299delAT in the GJB2 gene, c.538C > T in the GJB3
gene, c.IVS7-2A > G and c.2168A > G in the SLC26A4
gene, and m.1555A > G and m.1494C > T in the MT-
RNR1 gene. The analysis revealed that 22 probands
were negative for these mutations, and one carried the
monoallelic GJB2 c.235delC mutation. To further search
for the causative genes in these families, we performed
targeted genomic capture and MPS. For cases in which
novel variants were detected, segregation analysis was
performed to assess the family. A total of 195 ethnicity-
matched individuals were selected as controls to con-
firm the candidate mutations. This study was approved
by the Ethical Committee of Nanjing Medical University
for Human Studies. All participants provided written in-
formed consent that complied with all Declaration of
Helsinki tenets.Targeted genomic capture and next-generation
sequencing
Whole-exon regions of 104 deafness genes and three
microRNA regions (Additional file 1: Table S1)
were target-enriched using a Target Enrichment Kit
(MyGenostics Inc., Beijing, China) as previously de-
scribed [11]. A minimum of 3 μg of DNA was used to
generate indexed Illumina libraries according to the
manufacturer’s protocol. The final library size was 300
to 400 bp, including the adapter sequences. The en-
richment libraries were sequenced on an Illumina
HiSeq 2000 sequencer to generate 100 bp paired-end
reads. Next, high-quality reads were identified by fil-
tering out low-quality reads and adaptor sequences
using Solexa QA package [12] and Cutadapt program,
respectively. Variants were first selected if they appeared
in the 1000 Genomes Project database with an MAF
of >0.05, and then they were selected if they appeared in
the 300 local Asian Genome database. The remaining vari-
ants were further processed according to the dbSNP data-
base. SNPs and indels were identified using SOAPsnp and
GATK programs. Subsequently, the reads were realigned
to the reference genome (NCBI37/hg19) using BWA soft-
ware. Non-synonymous variants were evaluated by four
algorithms, including PolyPhen, SIFT, PANTHER and
Pmut, to determine pathogenicity [13].
Mutation validation and analysis
Sanger sequencing was performed on 51 available members
of seven families. Seven pairs of primers surrounding the
suspected variants were designed with Primer Premier 5.0
(Premier Biosoft) (Additional file 2: Table S2). PCR prod-
ucts were purified and sequenced with a BigDye Termin-
ator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster
City, CA, USA) and ABI 3730 DNA Sequencer (Applied
Biosystems, Foster City, CA, USA) with Chromas Lite
v2.01 (Technelysium Pty Ltd., Tewantin, QLD, Australia)
software. DNA sequence variation was identified through a
comparison of subjects’ DNA sequences to those of WFS1
(NM_001145853), COCH (NM_001135058), ACTG1 (NM_
001199954), TMC1 (NM_138691), POU4F3 (NM_002700),
and USH2A (NM_206933).
Possible pathogenic effects caused by the rare or
novel non-synonymous SNPs were evaluated by Muta-
tion Taster (http://www.mutationtaster.org), PROVEAN
(http://provean.jcvi.org) and SIFT (with cut-off scores
of −1.3 and 0.05, respectively; http://sift.jcvi.org). Multiple
sequence alignments were performed using ClustalW,
with the default setting of nine species.
Results
Deaf panel enrichment and targeted sequencing
The enriched libraries were labeled with a unique bar-
coding sequence, pooled, and sequenced on an Illumina
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length. As shown in Table 1, the average sequencing
depths of the targeted regions were 188 to 264. Over
98% coverage of the targeted regions was achieved for
each proband. The coverage of the targeted exons for
the >10× reads ranged from 94.10% to 96.20% and from
92.60% to 94.80% for the >20× reads. All mitochondrial
DNA and microRNA regions were sequenced at a depth
of over 100×. Using SOAPsnp, we identified an average of
485 to 656 variants for each sample. To give priority to
identification of the deleterious mutations, we adopted a
series of filtering strategies to focus on non-synonymous
variants (missense, nonsense and splice variants) using a
combination of filtering against HapMap 28, SNP data-
bases and mutiple algorithms (PolyPhen, SIFT, PANTHER
and Pmut). We found six deleterious non-synonymous
mutations: COCH, p.G38D; WFS1, p.R653C; ACTG1,
p.E316K; TMC1, p.D572N; POU4F3, p.P164R and USH2A,
p.P1684L. Of the indels, a total of 5 ~ 26 coding indels ini-
tially discovered in the probands using the GATK program,
only one deletion (WFS1, p.E680del) to be identified based
on the sample filtering strategy. Through the above ana-
lysis, we successfully validated the deleterious candidate
variants in the seven families.
Verification of candidate mutations in seven families
Six families with candidate variants (JSNY-021, JSNY-027,
JSNY-033, JSNY-043, JSNY-053 and JSNY-056) showed
autosomal dominant inheritance (Figure 1a). For all af-
fected members of each family, late-onset, progressive
hearing loss was observed. Pure-tone audiograms showed
bilaterally symmetric, sensorineural, mild-to-profound
deafness (Figure 1b). With regard to audiometric configu-
rations, two pedigrees were up-sloping (JSNY-021 and
JSNY-033), and the others exhibited down-sloping or flat
patterns. Aside from their hearing loss, the patients were
phenotypically normal. None of them complained of ves-
tibular symptoms. In each of the probands, multiple po-
tentially functional variants with predicted damaging
effects were identified by our approach and validated by
Sanger sequencing. Each validated variant was tested for











JSNY-021 III3 335538 329163 98.10 1
JSNY-027 III4 335538 329834 98.30 1
JSNY-033 II3 335538 332518 99.10 2
JSNY-043 III3 335538 333189 99.30 2
JSNY-045 II3 335538 330675 98.55 2
JSNY-053 III4 335538 331089 98.67 1
JSNY-056 III1 335538 329965 98.34 2family, and this assessment included an additional 28
affected individuals and 13 unaffected family members. Fi-
nally, six variants were successfully confirmed in the
WFS1 (n = 2), COCH, ACTG1, TMC1, and POU4F3 genes
(Table 2). Of them, three were novel missense mutations
(p.G38D in COCH, p.E316K in ACTG1, and p.P164R in
POU4F3), one was a novel in-frame indel mutation
(c.2036-2038delAGG in WFS1), and two were known
deafness-causing mutations that have been previously re-
ported (p.R653C inWFS1 and p.D572N in TMC1).
Another family possessed a candidate variant (JSNY-045)
exhibiting autosomal recessive inheritance. Both siblings
II-2 and II-3 suffered from severe sensorineural hearing
loss that was congenital and non-progressive (Figure 2a).
None of them reported eye problems. Complete ophthal-
mic examination showed negative findings (Table 3). Dur-
ing routine mutation detection, the proband (II-3) was
found to be a carrier of the monoallelic GJB2 c.235delC
mutation. Subsequent targeted capture sequencing of
known deafness genes confirmed the presence of this mu-
tation as well as of a newly detected heterozygous USH2A
gene mutation (c.5051C > T, p.P1684L) located in exon 25
(Figure 2c). We then used Sanger sequencing to screen
the proband’s sibling and parents. The results showed that
the sibling possessed the same genotype as the proband
(Figure 2b), while the parents were each unaffected het-
erozygotes carrying a GJB2 c.235delC monoallelic muta-
tion (the father) or a USH2A c.5051C > T monoallelic
mutation (the mother).
To predict the probable pathogenic effects of the above
variants, we analyzed the evolutionary conservation and
damaging effects of the amino acid substitutions. The re-
sults showed that all 7 of these variants were highly con-
served among multiple vertebrate species (Figure 2d,
Additional file 3: Figure S1). The results from the predic-
tion analysis are shown in Table 2.
None of the candidate mutations was found in the 195
Chinese Han healthy controls.
Discussion
In the present study, we confirmed the presence of seven








90 96.69 94.10 92.60
88 97.00 95.80 93.50
64 97.56 95.30 93.60
59 98.00 96.10 94.80
23 97.39 95.70 93.30
99 98.19 96.20 94.50
45 96.96 94.50 92.30
Figure 1 Pedigrees and audiograms of 6 DFNA families. (a) Family pedigrees showing autosomal dominant inheritance. Open symbols,
unaffected; solid black symbols, affected; squares, men; circles, female; arrows at lower left, probands. (b) Pure-tone audiograms of affected
members in each family. All hearing thresholds shown here are from the better ear. The red line indicates the proband.
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[WFS1 (n = 2), ACTG1, POU4F3, COCH and TMC1], and
one showed two monoallelic and most likely causative
mutations in the GJB2 and USH2A genes, respectively.
With the exception of the p.R653C mutation inWFS1 and
the p.D572N mutation in TMC1, the other five variants
have not been previously reported to be associated with
hereditary hearing loss. The causative genes detected in
the remaining 16 families require further examination,
presumably by linkage analysis and/or WES. It is probable
that hearing loss in these families is due to mutations in
unidentified deafness-related genes. Alternatively, patho-
genic mutations might exist in those regions not covered
in our sequencing analysis, including intronic regulatory
sequences.
In the JSNY-021 family, a novel in-frame indel muta-
tion caused by c.2036_2038delAGG (p.E680del) was de-
tected in WFS1, which is responsible for DFNA6/14/38Table 2 Mutations identified in 7 families













JSNY-027 COCH DFNA9 c. 113G > A Missense p.G38D
JSNY-033 WFS1 DFNA6/14/38 c.1957C > T Missense p.R653C
JSNY-043 ACTG1 DFNA20/26 c.946G > A Missense p.E316K
JSNY-053 TMC1 DFNA36 c.1714G > A Missense p.D572N
JSNY-056 POU4F3 DFNA15 c.491 C > G Missense p.P164R
Recessive
JSNY-045 USH2A 1q41 c.5051G > A Missense p.P1684L
aNegative and positive scores indicate deleterious and neutral, respectively, with cu
cut-off score set at 0.05. cDC: Disease causing.hearing loss. This gene encodes wolframin, which is a
membrane glycoprotein predominantly located in the
endoplasmic reticulum (ER). This protein is essential
for maintaining correct levels of Ca2+ and other charged
particles necessary for hearing, and its lack of function in-
duces apoptotic input signaling in the ER [16,17]. Although
it remains unknown whether wolframin is expressed in
the human cochlea, mutations in the WFS1 gene, such
as c.511G > A (p.D171N), c.2005 T > C (p.Y669H) and
c.2590G > A (p.E864K), have been identified as frequent
causes of autosomal dominant low-frequency hearing
loss in different ethnicities [18-20]. The heterozygous 3-
bp deletion (c.2036_2038delAGG) identified in the
present study is expected to cause the loss of the E680
codon, which might affect the three-dimensional shape
or properties of the wolframin protein and consequently
interfere the normal function of the wolframin tetramer.









4/8 DCc - - 0.00 Novel
14/4 DC −1.431 0.00 0.00 Novel
4/8 DC −3.501 0.98 0.00 Awata
et al. [14]
17/5 DC −2.648 0.01 0.00 Novel
9/19 DC −2.499 0.21 0.00 Kurima
et al. [15]
5/2 DC −2.112 0.34 0.00 Novel
1/25 DC −4.567 0.00 0.00 Novel
t-off score set at −1.3; bScore ranges from 0 (deleterious) to 1 (neutral), with
Figure 2 (See legend on next page.)
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Figure 2 DFNB in the affected family segregated with the GJB2 c.235delC and USH2A c.5051C > T mutations. (a) Family pedigree of
JSNY-045 and audiograms of two deaf siblings and their parents. (b) The average coverage of each exon of the GJB2 and USH2A genes in the
proband (left) and sequencing electropherograms of the heterozygous GJB2 c.235delC and USH2A c.5051C > T mutations (right). (c) A novel
c.5051C > T variant and six previously reported mutations in USH2A exon 25. (d) Conservation analysis of the novel missense mutation. The USH2A
p.P1684L mutation occurs at an evolutionarily conserved amino acid (in red box).
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study, we hypothesize that this mutation likely has a
pathogenic effect.
ACTG1 encodes cytoskeletal actin gamma 1, which is
known to be the building block of hair cell stereocilia.
These stereocilia are constantly undergoing actin
polymerization at their tips and depolymerization at
their bases [21]. In auditory hair cells of the cochlea and
intestinal epithelial cells, actin gamma 1 has a predominant
and unique expression pattern. Mutations in the ACTG1
gene have been mainly associated with autosomal domin-
ant progressive sensorineural deafness 20/26 (DFNA20/
26), and some have been linked to Baraitser-Winter syn-
drome, which is a rare autosomal recessive disorder char-
acterized by developmental delay, facial dysmorphology,
brain malformations, coloboma, and variable hearing loss
[22-24]. To date, a total of 19 ACTG1 mutations have been
reported in patients with DFNA 20/26 and Baraitser-
Winter syndrome, of which 12 have been identified in
NSHL families (http://www.hgmd.org/, designed by P.D.
Stenson HGMD®). In this study, we found the novel mis-
sense mutation p.E316K, which was caused by a c.946 G >
A transition in ACTG1, in the JSNY-043 family. p.E316K
is located in subdomain 3 of actin gamma 1, which is a
highly conserved actin domain of ACTG1. Until now, all
reported ACTG1 missense mutations have been located in
this domain.
The POU4F3 protein is a well-known transcription factor
encoded by POU4F3. This protein belongs to the POU-
domain class IV transcription factor family and plays an im-
portant role in the maturation, differentiation and survival
of hair cells [25]. Mutations in the POU4F3 gene have been
described in patients with nonsyndromic sensorineural
deafness autosomal dominant type 15 (DFNA15). To date,
more than five different mutation types, including the dele-






PTAa (dBHL) Vestibular func
II3 Male 28 78.75 Normal
II2 Female 30 88.75 Normal
I1 Male 55 18.75 Normal
I2 Female 53 18.75 Normal
aPTA: pure tone average of 0.5, 1, 2, and 4 kHz for the better ear; bERG: electroretinreported worldwide in different ethnic groups [26,27], but
none have been reported in the Asian population. In the
present study, the POU4F3 p.P164R missense mutation
caused by c.491C >G was identified as a novel mutation in
the JSNY-056 Chinese family.
The COCH gene encodes a 550-amino acid protein
with multiple domains, including a signal peptide (SP),
an LCCL module and two von Willebrand factor A
(vWFA) domains [28]. The COCH protein, cochlin, is
abundantly expressed in the cochlea and vestibular system
of the inner ear. Mutations in the COCH gene lead to
autosomal dominant nonsyndromic sensorineural deaf-
ness 9 (DFNA9), which has been clinically characterized
by progressive late-onset hearing loss with or without ves-
tibular dysfunction [29]. Presently, 18 COCH mutations
have been identified in DFNA9 families (http://www.
hgmd.org/, designed by P.D.Stenson HGMD®), most of
which are located in the LCCL region. Here, we identified
a novel missense mutation (c.113G >A, p.G38D) in exon 3
of the COCH gene, which is the LCCL domain of cochlin.
Mutations in this domain are expected to cause misfolding
and protein aggregation in a dominant-negative manner,
leading to cytotoxicity of the inner ear fibrocytes [30]. The
clinical features associated with this novel mutation in the
JSNY-027 family lends support to the pathogenic nature of
the p.G38D variant.
In the present study, we also identified one novel mu-
tation of USH2A c.5051C > A (p.P1684L) in the JSNY-
045 family. USH2 mutations result in an autosomal
recessive disorder characterized by retinitis pigmentosa
and mild-to-moderate sensorineural hearing loss, and
the USH2A gene is most commonly mutated. This gene
is located at 1q41 and encodes a protein with a predicted
size of 171.5 kDa [31,32]. To date, more than 120 differ-
ent disease-causing mutations have been reported in the
USH2A gene, which are widely distributed over thetion Night blindness Visual fields Photophobia ERGb
No Normal No Normal
No Normal No Normal
No Normal No Normal
No Normal No Normal
ogram.
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p.P1684L mutation, which is located in exon 25 of the
USH2A gene, was identified together with the GJB2
c.235delC mutation in two deaf siblings of the JSNY-045
family, while their hearing parents each carried only one
monogenic recessive mutation. All subjects exhibited
normal vestibular and visual functions. We therefore de-
duced that the USH2A monogenic recessive mutation
failed to cause the Usher phenotype but may have con-
tributed to the pathogenesis of the GJB2 c.235delC mu-
tation, resulting in phenotypic hearing loss in the two
patients. In fact, digenic inheritance of nonsyndromic
deafness caused by mutations in the GJB2 gene and
other connexin genes, such as GJB3, GJB6, GJB4, or
GJA1, have been previously reported in several deaf pa-
tients [33-35]. In addition, a Japanese family with co-
morbid GJB2 and WFS1 mutations was also described
in 2012. In this family, one individual with mutations in
both GJB2 and WFS1 presented with a GJB2 phenotype
[36]. Our results together with previous findings suggest
that monoallelic GJB2 mutations may contribute to NSHL
as a result of their co-inheritance with other deafness-
causing genes. However, the pathogenic mechanisms
underlying the cooperation of these genes with GJB2 re-
quire further research.
Conclusions
Using targeted genomic capture and MPS, we have suc-
cessfully identified causative gene mutations in six families
with autosomal dominant NSHL, and in patients from a
family with recessive DFNB, we detected two monoallelic
mutations in the GJB2 and USH2A genes, respectively.
The USH2A gene may have cooperated with GJB2 to
cause the NSHL phenotype in this Chinese family. Our re-
sults suggest that targeted genomic capture combined
with MPS can serve as a useful technique in the etiological
diagnosis of sensorineural hearing loss.Additional files
Additional file 1: Table S1. Target genes and regions of the DeafPanel.
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variants of 7 genes.
Additional file 3: Figure S1. Sanger sequencing and conservation
analysis of gene mutations identified in 6 autosomal dominant
families. (a) WFS1 c.2036_2038delAGG (p.E680del) in-frame indel
mutation in the JSNY-021 family. (b) COCH c.113G > A (p.G38D)
missense mutation in the JSNY-027 family. (c) WFS1 c.1957C > T
(p.R653C) missense mutation in the JSNY-033 family. (d) ACTG1 c.946G > A
(p.E316K) missense mutation in the JSNY-043 family. (e) TMC1 c.1714G > A
(p.D572N) missense mutation in the JSNY-053 family. (f) POU4F3 c.491C > G
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